eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hartnup disease |
| Comorbidity | C0021845|intestinal perforation |
| Sentences | 1 |
| PubMedID- 23788866 | However, the administration of mntx may be associated with an increased risk of gastrointestinal perforation in patients with diseases that decrease gut wall integrity (cancer, peptic ulceration and ogilvie's syndrome) or concomitant medications (nsaids, bevacizumab). |
Page: 1